1. Home
  2. Labeler Index
  3. Remedyrepack Inc.
  4. 70518-3239
  5. NDC Package Code: 70518-3239-0 Mesalamine

NDC Package 70518-3239-0 Mesalamine

Capsule, Delayed Release Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70518-3239-0
Package Description:
30 POUCH in 1 BOX / 1 CAPSULE, DELAYED RELEASE in 1 POUCH (70518-3239-1)
Product Code:
70518-3239
Proprietary Name:
Mesalamine
Non-Proprietary Name:
Mesalamine
Substance Name:
Mesalamine
Usage Information:
This medication is used to treat a certain bowel disease (ulcerative colitis). It helps to reduce symptoms of ulcerative colitis such as diarrhea, rectal bleeding, and stomach pain. Mesalamine belongs to a class of drugs known as aminosalicylates. It works by decreasing swelling in the colon.
11-Digit NDC Billing Format:
70518323900
NDC to RxNorm Crosswalk:
  • RxCUI: 1368954 - mesalamine 400 MG Delayed Release Oral Capsule
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Remedyrepack Inc.
    Dosage Form:
    Capsule, Delayed Release - A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • MESALAMINE 400 mg/1
    • Pharmacologic Class(es):
  • Aminosalicylate - [EPC] (Established Pharmacologic Class)
  • Aminosalicylic Acids - [CS]
    • Sample Package:
    No
    FDA Application Number:
    NDA204412
    Marketing Category:
    NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
    Start Marketing Date:
    10-13-2021
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 70518-3239-0?

    The NDC Packaged Code 70518-3239-0 is assigned to a package of 30 pouch in 1 box / 1 capsule, delayed release in 1 pouch (70518-3239-1) of Mesalamine, a human prescription drug labeled by Remedyrepack Inc.. The product's dosage form is capsule, delayed release and is administered via oral form.

    Is NDC 70518-3239 included in the NDC Directory?

    Yes, Mesalamine with product code 70518-3239 is active and included in the NDC Directory. The product was first marketed by Remedyrepack Inc. on October 13, 2021 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 70518-3239-0?

    The 11-digit format is 70518323900. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-170518-3239-05-4-270518-3239-00